200 related articles for article (PubMed ID: 2663160)
1. Comparison of once-daily cephalosporin regimens for community-acquired lower respiratory tract infections in patients with chronic lung disease.
McCabe RE; Schlossberg D; Donowitz GR; Scheld WM; Zellner SR; Lindenberg LB; Armstrong JH; Ein ME
Clin Ther; 1989; 11(3):304-14. PubMed ID: 2663160
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
[TBL] [Abstract][Full Text] [Related]
3. Role of long-acting cephalosporins in ambulatory therapy.
Prichard JG
Clin Ther; 1988; 10(6):688-93. PubMed ID: 3219684
[TBL] [Abstract][Full Text] [Related]
4. Cefodizime once daily in the treatment of lower respiratory tract infections.
Piovano CF; Palombini BC; Dagrosa EE; Mendoza F; Facco EB
Arzneimittelforschung; 1997 May; 47(5):674-7. PubMed ID: 9205786
[TBL] [Abstract][Full Text] [Related]
5. Ofloxacin in the treatment of lower respiratory tract infections: report of a prospective, comparative trial.
Khajotia RR; Vetter N; Harazin H
Clin Ther; 1991; 13(4):460-6. PubMed ID: 1933997
[TBL] [Abstract][Full Text] [Related]
6. A study evaluating the efficacy, safety, and tolerability of ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults.
Ortiz-Ruiz G; Caballero-Lopez J; Friedland IR; Woods GL; Carides A;
Clin Infect Dis; 2002 Apr; 34(8):1076-83. PubMed ID: 11914996
[TBL] [Abstract][Full Text] [Related]
7. Comparison of cefonicid and cefamandole for the treatment of community-acquired infections of the lower respiratory tract.
Geckler RW; McCormack GD; Goodman JS
Rev Infect Dis; 1984; 6 Suppl 4():S847-52. PubMed ID: 6395275
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis.
DeAbate CA; Bettis R; Munk ZM; Fleming H; Munn NJ; Riffer E; Bagby B; Giguere G; Collins JJ
Clin Ther; 1999 Jan; 21(1):172-88. PubMed ID: 10090434
[TBL] [Abstract][Full Text] [Related]
9. Comparative clinical evaluation of ceftriaxone in treating lower respiratory tract infections.
Abbate GF; Alagia I; Giaquinto E; Leonessa V; Caputi M; Guarino C; Micillo E; Catena E; Altucci P
Chemioterapia; 1986 Feb; 5(1):26-32. PubMed ID: 3955779
[TBL] [Abstract][Full Text] [Related]
10. Ofloxacin in community-acquired lower respiratory infections. A comparison with amoxicillin or erythromycin.
Stocks JM; Wallace RJ; Griffith DE; Garcia JG; Kohler RB
Am J Med; 1989 Dec; 87(6C):52S-56S. PubMed ID: 2690620
[TBL] [Abstract][Full Text] [Related]
11. Effects of prior effective therapy on the efficacy of daptomycin and ceftriaxone for the treatment of community-acquired pneumonia.
Pertel PE; Bernardo P; Fogarty C; Matthews P; Northland R; Benvenuto M; Thorne GM; Luperchio SA; Arbeit RD; Alder J
Clin Infect Dis; 2008 Apr; 46(8):1142-51. PubMed ID: 18444848
[TBL] [Abstract][Full Text] [Related]
12. A randomized clinical trial comparing the safety and efficacy of cefonicid and cefamandole in the treatment of patients with respiratory tract infections caused by susceptible pathogens.
Azanza JR; Honorato J; Rubio A; Cuena R
Chemioterapia; 1987 Jun; 6(2 Suppl):449-51. PubMed ID: 3334597
[No Abstract] [Full Text] [Related]
13. Use of long half-life parenteral cephalosporins in ambulatory practice.
Sauerwein M; Deamer RL; Prichard JG
J Fam Pract; 1987 Jan; 24(1):47-51. PubMed ID: 3794613
[TBL] [Abstract][Full Text] [Related]
14. [Multicentre, randomized, prospective and comparative study of ceftriaxone, cefotaxime and cefuroxime in treating mild to moderate respiratory tract infection].
Gao B; Hu J; Deng W
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):528-31. PubMed ID: 11360502
[TBL] [Abstract][Full Text] [Related]
15. Intravenous fleroxacin versus ceftazidime in the treatment of acute nonpneumococcal lower respiratory tract infections.
Farkas SA
Am J Med; 1993 Mar; 94(3A):142S-149S. PubMed ID: 8452171
[TBL] [Abstract][Full Text] [Related]
16. Comparative trial of cefonicid and cefamandole in the therapy of community-acquired pneumonia.
Wallace RJ; Niefield SL; Waters S; Waters B; Awe RJ; Wiss K; Martin RR; Greenberg SB
Antimicrob Agents Chemother; 1982 Feb; 21(2):231-5. PubMed ID: 7041813
[TBL] [Abstract][Full Text] [Related]
17. A comparison of a five-day regimen of cefdinir with a seven-day regimen of loracarbef for the treatment of acute exacerbations of chronic bronchitis.
Paster RZ; McAdoo MA; Keyserling CH; Nemeth MA; Tack KJ; Griffin TJ
Int J Clin Pract; 2000 Jun; 54(5):293-9. PubMed ID: 10954955
[TBL] [Abstract][Full Text] [Related]
18. Clarithromycin versus cefaclor in lower respiratory tract infections. The Canadian Bronchitis Study Group.
Fong IW; Laforge J; Dubois J; Small D; Grossman R; Zakhari R
Clin Invest Med; 1995 Apr; 18(2):131-8. PubMed ID: 7788958
[TBL] [Abstract][Full Text] [Related]
19. [Ceftriaxone in the therapy of infections of the lower respiratory tract: comparison with cefotaxime].
Lanni N; Scaglione B
Minerva Med; 1986 Mar; 77(9-10):317-9. PubMed ID: 3485265
[TBL] [Abstract][Full Text] [Related]
20. [Double-blind comparison of cefamandole and cefazolin in the therapy of respiratory tract infections (author's transl)].
Jpn J Antibiot; 1980 Mar; 33(3):375-409. PubMed ID: 6995640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]